diclofenac has been researched along with Cerebrovascular Disorders in 2 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samartsev, IN | 1 |
| Zhivolupov, SA | 1 |
| Butakova, JS | 1 |
| Parshin, MS | 1 |
| Nadesalingam, K | 1 |
| Kirby, D | 1 |
2 other studies available for diclofenac and Cerebrovascular Disorders
| Article | Year |
|---|---|
[The open observational study of aceclofenac and vinpocetine effectiveness and tolerability in treatment of patients with chronic cerebrovascular disease after COVID-19 (AQUA study)].
Topics: Aged; Cerebrovascular Disorders; COVID-19; COVID-19 Drug Treatment; Diclofenac; Female; Humans; Male | 2021 |
Cardiovascular safety of non-steroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cerebrovascular Disorders; Contraindications; Diclofenac; D | 2013 |